GP1BA and Von Willebrand disease: Intriguingly, this measurement is consistent with a model of A1 affinity regulation based on A1 and A1–GPIbα crystal structures, and the localization of von Willebrand disease gain of function mutations in the A1 domain near its long-range disulfide bond5–7.